[HTML] cell.comFull View

[HTML][HTML] Artemisinins target GABAA receptor signaling and impair α cell identity

J Li, T Casteels, T Frogne, C Ingvorsen, C Honore… - Cell, 2017 - cell.com
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …
被引用次数：389 相关文章

Artemisinins Target GABA A Receptor Signaling and Impair α Cell Identity

J Li, T Casteels, T Frogne, C Ingvorsen, C Honoré… - Cell, 2017 - hal.science
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …
[HTML] sciencedirect.com

[HTML][HTML] Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

J Li, T Casteels, T Frogne, C Ingvorsen, C Honoré… - Cell, 2017 - Elsevier
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …
[HTML] cell.com

[HTML][HTML] Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

J Li, T Casteels, T Frogne, C Ingvorsen, C Honoré… - Cell, 2017 - cell.com
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …

Artemisinins target GABAA receptor signaling and impair α cell identity

J Li, T Casteels, T Frogne - Cell, 2017 - dialnet.unirioja.es
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …

Artemisinins target GABAA receptor signaling and impair α cell identity.

LJ Li Jin, T Casteels, T Frogne, C Ingvorsen, C Honoré… - 2017 - cabidigitallibrary.org
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …
[HTML] nih.gov

[HTML][HTML] Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

J Li, T Casteels, T Frogne, C Ingvorsen, C Honoré… - Cell, 2017 - ncbi.nlm.nih.gov
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …

Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

J Li, T Casteels, T Frogne, C Ingvorsen, C Honoré… - Cell, 2017 - pubmed.ncbi.nlm.nih.gov
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating
new insulin-producing cells from other cell types is a major aim of regenerative medicine …

[引用][C] Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

J Li, T Casteels, T Frogne, C Ingvorsen, C Honoré… - Cell, 2017 - cir.nii.ac.jp
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[PDF] aliyuncs.com

[PDF][PDF] Artemisinins Target GABAA Receptor Signaling and Impair a Cell Identity

J Li, T Casteels, T Frogne, C Ingvorsen… - …, 2017 - ckcest-crawler-data.oss-cn-beijing …
Type 1 diabetes is characterized by the destruction of pancreatic b cells, and generating
new insulinproducing cells from other cell types is a major aim of regenerative medicine …